Caisse Des Depots ET Consignations Buys Shares of 17,298 HealthEquity, Inc. (NASDAQ:HQY)

Caisse Des Depots ET Consignations purchased a new position in shares of HealthEquity, Inc. (NASDAQ:HQYFree Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 17,298 shares of the company’s stock, valued at approximately $1,660,000.

A number of other large investors have also made changes to their positions in the business. Arcadia Investment Management Corp MI acquired a new position in HealthEquity during the 4th quarter valued at about $26,000. Smartleaf Asset Management LLC increased its holdings in shares of HealthEquity by 34.3% during the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock valued at $37,000 after acquiring an additional 98 shares in the last quarter. Proficio Capital Partners LLC purchased a new position in shares of HealthEquity in the 4th quarter valued at approximately $39,000. UMB Bank n.a. raised its position in shares of HealthEquity by 65.6% in the 4th quarter. UMB Bank n.a. now owns 414 shares of the company’s stock valued at $40,000 after purchasing an additional 164 shares during the last quarter. Finally, Skandinaviska Enskilda Banken AB publ boosted its stake in HealthEquity by 1,934.8% in the 4th quarter. Skandinaviska Enskilda Banken AB publ now owns 468 shares of the company’s stock worth $45,000 after purchasing an additional 445 shares in the last quarter. 99.55% of the stock is owned by institutional investors and hedge funds.

HealthEquity Stock Performance

Shares of NASDAQ HQY opened at $88.83 on Friday. HealthEquity, Inc. has a 1 year low of $65.01 and a 1 year high of $115.59. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. The company’s fifty day moving average price is $103.94 and its 200 day moving average price is $95.84. The company has a market capitalization of $7.68 billion, a PE ratio of 81.50, a price-to-earnings-growth ratio of 1.60 and a beta of 0.62.

Analysts Set New Price Targets

A number of research analysts have issued reports on the stock. The Goldman Sachs Group decreased their price target on shares of HealthEquity from $107.00 to $94.00 and set a “neutral” rating for the company in a report on Thursday. Mizuho began coverage on HealthEquity in a research report on Wednesday, December 4th. They set an “outperform” rating and a $126.00 price target for the company. Raymond James raised HealthEquity from an “outperform” rating to a “strong-buy” rating and cut their price objective for the company from $120.00 to $115.00 in a report on Tuesday. Royal Bank of Canada lifted their target price on HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a report on Tuesday, December 10th. Finally, JMP Securities increased their price target on shares of HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a report on Tuesday, December 10th. One equities research analyst has rated the stock with a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Buy” and a consensus price target of $112.23.

Read Our Latest Stock Analysis on HealthEquity

Insider Transactions at HealthEquity

In other news, Director Robert W. Selander sold 5,750 shares of the company’s stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the completion of the transaction, the director now directly owns 78,219 shares of the company’s stock, valued at $8,704,992.51. This represents a 6.85 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Corporate insiders own 2.20% of the company’s stock.

HealthEquity Company Profile

(Free Report)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

See Also

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.